2025 annual financial data
Vistagen Therapeutics 2025 Operating margin
Vistagen Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -11,517.08%.
Operating income was -55,973,000 USD and net income was -51,418,000 USD.
Operating cash flow was -42,097,000 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 486,000 USD
- Operating income
- -55,973,000 USD
- Net income
- -51,418,000 USD
- Operating cash flow
- -42,097,000 USD